Reducing the risk of failure: biomarker-guided trial design

被引：12
|
作者：
Townsend, Michael J. [1 ]
Arron, Joseph R. [2 ]
机构：
[1] Genentech Inc, Biomarker Discovery OMNI, 1 DNA Way, San Francisco, CA 94080 USA
[2] Genentech Inc, Immunol Discovery, 1 DNA Way, San Francisco, CA 94080 USA
来源：
NATURE REVIEWS DRUG DISCOVERY | 2016年 / 15卷 / 08期
关键词：
D O I：
10.1038/nrd.2016.124
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Drug candidates may fail in clinical trials for many reasons. Biomarker-guided clinical trial design can mitigate the risk of failure and enable more informative clinical experiments regardless of outcomes.
引用
收藏
页码：517 / 518
页数：2
相关论文
共 50 条
  • [1] Reducing the risk of failure: biomarker-guided trial design
    Michael J. Townsend
    Joseph R. Arron
    Nature Reviews Drug Discovery, 2016, 15 : 517 - 518
  • [2] Evaluating statistical characteristics of biomarker-guided trial designs
    Miranta Antoniou
    Andrea Jorgensen
    Ruwanthi Kolamunnage-Dona
    Trials, 16
  • [3] Evaluating statistical characteristics of biomarker-guided trial designs
    Antoniou, Miranta
    Jorgensen, Andrea
    Kolamunnage-Dona, Ruwanthi
    TRIALS, 2015, 16
  • [4] Biomarker-Guided Therapies in Heart Failure: A Forum for Unified Strategies
    Fiuzat, Mona
    O'Connor, Christopher M.
    Gueyffier, Francois
    Mascette, Alice M.
    Geller, Nancy L.
    Mebazaa, Alexandre
    Voors, Adriaan A.
    Adams, Kirkwood F.
    Pina, Ileana L.
    Neyses, Ludwig
    Muntendam, Pieter
    Felker, G. Michael
    Pitt, Bertram
    Zannad, Faiez
    Bristow, Michael R.
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (08) : 592 - 599
  • [5] Biomonitoring and Biomarker-Guided Therapy The Next Step in Heart Failure and Biomarker Research
    Maisel, Alan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (18) : 1890 - 1892
  • [6] Biomarker-Guided Tailored Therapy
    Lydiard, Jessica
    Nemeroff, Charles B.
    FRONTIERS IN PSYCHIATRY: ARTIFCIAL INTELLIGENCE, PRECISION MEDICINE, AND OTHER PARADIGM SHIFTS, 2019, 1192 : 199 - 224
  • [7] Improving clinical trial efficiency by biomarker-guided patient selection
    Ruud Boessen
    Hiddo J Lambers Heerspink
    Dick De Zeeuw
    Diederick E Grobbee
    Rolf HH Groenwold
    Kit CB Roes
    Trials, 15
  • [8] Improving clinical trial efficiency by biomarker-guided patient selection
    Boessen, Ruud
    Heerspink, Hiddo J. Lambers
    De Zeeuw, Dick
    Grobbee, Diederick E.
    Groenwold, Rolf H. H.
    Roes, Kit C. B.
    TRIALS, 2014, 15
  • [9] Biomarker-guided management in acute heart failure: is there light at the end of the tunnel?
    Bayes-Genis, Antoni
    Emdin, Michele
    Nunez, Julio
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (02) : 276 - 278
  • [10] Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial
    Scriba, Thomas J.
    Fiore-Gartland, Andrew
    Penn-Nicholson, Adam
    Mulenga, Humphrey
    Mbandi, Stanley Kimbung
    Borate, Bhavesh
    Mendelsohn, Simon C.
    Hadley, Katie
    Hikuam, Chris
    Kaskar, Masooda
    Musvosvi, Munyaradzi
    Bilek, Nicole
    Self, Steven
    Sumner, Tom
    White, Richard G.
    Erasmus, Mzwandile
    Jaxa, Lungisa
    Raphela, Rodney
    Innes, Craig
    Brumskine, William
    Hiemstra, Andriette
    Malherbe, Stephanus T.
    Hassan-Moosa, Razia
    Tameris, Michele
    Walzl, Gerhard
    Naidoo, Kogieleum
    Churchyard, Gavin
    Hatherill, Mark
    LANCET INFECTIOUS DISEASES, 2021, 21 (03): : 354 - 365
12345